BC Week In Review | Jul 13, 2018
Financial News

Assembly raises $144M follow-on

Assembly Biosciences Inc. (NASDAQ:ASMB) raised $144 million late on July 11 through the sale of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities, Baird and National Securities...
BC Extra | Jul 12, 2018
Financial News

Assembly raises $144M follow-on

Assembly Biosciences Inc. (NASDAQ:ASMB) raised $144 million late Wednesday through the sale of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities, Baird and National Securities Corp. The...
BC Week In Review | Jan 12, 2017
Company News

Assembly, Allergan deal

Assembly granted Allergan exclusive, worldwide rights to preclinical candidates ABI-M201, which is in development for ulcerative colitis; and ABI-M301, which is in development for Crohn’s disease. The deal also includes two undisclosed compounds in discovery...
BC Extra | Jan 10, 2017
Company News

Allergan in deals with Lysosomal Therapeutics, Assembly

Allergan plc (NYSE:AGN) announced two deals Monday, gaining an exclusive option to acquire neurodegenerative disease company Lysosomal Therapeutics Inc. (Cambridge, Mass.) and a license for rights to four gastrointestinal microbiome programs from Assembly BioSciences Inc....
Items per page:
1 - 4 of 4